180 mg WATSON 663 (Diltiazem CD 180 mg/24 hours)
Pill imprint 180 mg WATSON 663 has been identified as Diltiazem hydrochloride CD 180 mg/24 hours.
Diltiazem is used in the treatment of atrial fibrillation; high blood pressure; atrial flutter; supraventricular tachycardia; heart failure (and more), and belongs to the drug classes calcium channel blocking agents, group IV antiarrhythmics. Risk cannot be ruled out during pregnancy. Diltiazem 180 mg/24 hours is not a controlled substance under the Controlled Substance Act (CSA).
- Imprint:
- 180 mg WATSON 663
- Strength:
- 180 mg/24 hours
- Color:
- Pink & White
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Calcium channel blocking agents
Group IV antiarrhythmics - Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Watson Pharmaceuticals
More about diltiazem
Consumer resources
- Diltiazem
- Diltiazem 12-hour sustained-release capsules
- Diltiazem 24-hour extended-release beads capsules
- Diltiazem 24-hour extended-release beads tablets
- Diltiazem 24-hour sustained-release beads capsules
- More (4) »
- Other brands: Cardizem, Cartia XT, Taztia XT, Tiazac, More (7) »
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
